Announced
Completed
Synopsis
Veranex, a provider of the first purpose-built, global service platform for the medtech industry, completed the acquisition of T3 Labs, a preclinical laboratory. Financial terms were not disclosed. "The addition of T3 Labs to the Veranex family allows us to further realize our mission of unifying the entire medtech development process, from concept to commercialization. The growth of the preclinical market, increasing regulatory requirements, and the need for efficient collaboration between clients and their product development partners make T3 Labs a strategic fit for Veranex and an incredible asset for our clients," Pat Donnelly, Veranex CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.